Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

At ASH, drugmakers to showcase early data for three-pronged cancer therapies

J&J and AbbVie are among the companies advancing “trispecific” antibodies that could become another step forward in treatment for multiple myeloma.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

Tissue Engineering Takes Shape

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use. The post Tissue Engineering Takes Shape appeared first on GEN - Genetic Engineering and Biotechnology News .

Beyond Conventional CRISPR

Genome editing is not designed to replace neurons or retinal cells that have already been lost. In this article, experts from four companies—eGenesis, Epicrispr, KOMO Biosciences, and Sumitomo Pharma America—discuss how they are moving beyond conventional CRISPR to develop novel approaches for treating disease.

More from Thursday 5 November →